Hepatoblastoma Treatment in Turkey

Understanding Hepatoblastoma and Its Symptoms

Hepatoblastoma is a rare primary liver cancer that originates from immature liver cells (hepatoblasts). It most frequently affects infants and children under three years of age. Because the liver can expand within the abdominal cavity without causing immediate pain, the disease is often discovered at a later stage when an enlarged abdomen or a firm lump becomes noticeable.

Parents often seek medical advice after noticing specific physical changes. Common clinical features include:

• A noticeable mass or swelling in the upper right side of the abdomen
• Unexplained weight loss or poor weight gain
• Loss of appetite and persistent fatigue
• Abdominal discomfort or nausea
• Rarely, early puberty in young boys caused by hormone secretion (hCG) from the tumour

Early clinical evaluation within specialized oncology departments is critical to determine the extent of the lesion and prevent local or distant spread.

How Hepatoblastoma Is Diagnosed in Turkey

Evaluating paediatric liver tumours requires a multidisciplinary medical team, including paediatric oncologists, radiogenetic specialists, and liver surgeons. When traveling for care, families usually undergo thorough diagnostic confirmation at the treating medical centre.

Diagnostic protocols typically include:

• Serum Alpha-Fetoprotein (AFP) Testing: AFP is a tumour marker elevated in the majority of hepatoblastoma cases. It serves both as a diagnostic indicator and a metric for monitoring treatment response.
• Advanced Imaging: High-resolution ultrasound, multiphase dynamic MRI, or contrast-enhanced CT scans are used to map the liver anatomy, assess blood vessel involvement (portal vein and hepatic arteries), and calculate the PRETEXT (Pre-Treatment Extent of Disease) stage.
• Tissue Biopsy: A core needle biopsy may be performed to confirm the histological subtype unless immediate resection is indicated.
• Chest Imaging: CT scans of the lungs are performed to rule out pulmonary metastases.

Families traveling to Turkey should bring all previous diagnostic records, including original DICOM imaging files on CD/USB, histological slides or tissue blocks (if a biopsy was already performed), serum marker laboratory reports, and complete clinical summaries from their home paediatrician.

Treatment Options for Hepatoblastoma

Management of hepatoblastoma depends heavily on the tumour's PRETEXT staging, whether the lesion can be safely removed surgically at diagnosis, and the presence of metastatic disease. Treatment decisions are individualized by the multidisciplinary team following a comprehensive review of all tests.

Surgical intervention is the primary curative modality, but combination therapy incorporating systemic treatments provides the highest likelihood of disease control. In complex cases, additional specialized interventions managed under paediatrics and intensive care services may be required.

Planning Treatment and Travel to Turkey

Organising medical travel for a child with hepatoblastoma requires careful coordination between the international patient department, the clinical oncology team, and the family's local medical providers.

The planning process generally follows these steps:

• Pre-Travel Record Review: Pathologists and oncologists review sent medical records to provide an initial opinion on diagnostic thoroughness and feasible treatment pathways.
• In-Country Stay: Initial diagnostic staging and the first cycle of chemotherapy or surgical planning typically require an extended stay ranging from three to six weeks, depending on the intervention required.
• Post-Operative Recovery: If extensive liver resection is performed, the child will need dedicated hospital care followed by outpatient monitoring before clearance for air travel is granted.
• Follow-Up Care: Long-term follow-up involves periodic AFP blood tests and imaging. Coordination with local physicians at home ensures continuity of monitoring once the child returns.

When Travel Is Not Advisable and Warning Signs

International travel is not suitable for every child with hepatoblastoma. Severe clinical instability, acute liver failure, uncontrolled active infection, or severe low blood counts (neutropenia) make long-distance transit unsafe.

Immediate local medical evaluation is required if any of the following warning signs occur:

• Sudden, severe abdominal pain or rapid abdominal swelling (which may indicate tumour rupture or internal bleeding)
• High fever or signs of severe infection during or after chemotherapy
• Jaundice (yellowing of the skin or eyes) or persistent dark urine
• Severe shortness of breath or persistent coughing
• Extreme lethargy or inability to retain fluids

If these emergency signs appear before travel, families must seek immediate local emergency care rather than attempting to board an international flight.